Medexus Pharmaceuticals (MDP) Stock Chart & Stock Price History C$3.13 -0.04 (-1.26%) As of 07/2/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Medexus Pharmaceuticals Stock Price Performance The Medexus Pharmaceuticals (MDP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 60.51%, with a year-to-date return of -9.54%. In the past month, the stock has increased 5.74%, reflecting recent market activity. As of the latest close, Medexus Pharmaceuticals traded at C$3.13 with a market cap of C$70.08 million and volume of 37,144 shares. Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.63%1 Month Performance+5.74%3 Month Performance+36.09%Year-To-Date Performance-9.54%1 Year Performance+60.51% MDP Stock Chart for Thursday, July, 3, 2025 MDP Chart by TradingView Medexus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025C$3.17C$3.13-1.26%C$3.29C$3.1337,144 shsC$70.08 million07/01/2025C$3.17C$3.17C$3.24C$3.1514,211 shsC$70.97 million06/30/2025C$3.15C$3.17+0.63%C$3.24C$3.1514,211 shsC$70.97 million06/27/2025C$3.15C$3.15C$3.27C$3.1561,584 shsC$70.52 million06/26/2025C$3.35C$3.15-5.97%C$3.61C$3.06133,801 shsC$70.52 million06/25/2025C$3.28C$3.35+2.13%C$3.35C$3.2346,200 shsC$75 million06/24/2025C$3.40C$3.28-3.53%C$3.48C$3.2580,669 shsC$73.43 million06/23/2025C$3.22C$3.40+5.59%C$3.43C$3.2385,605 shsC$76.12 million06/20/2025C$3.17C$3.22+1.58%C$3.27C$3.1131,459 shsC$72.09 million06/19/2025C$3.09C$3.17+2.59%C$3.25C$3.0517,754 shsC$70.97 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025C$3.03C$3.09+1.98%C$3.20C$3.0539,399 shsC$69.18 million06/17/2025C$3.00C$3.03+1.00%C$3.10C$3.0035,137 shsC$67.84 million06/16/2025C$2.93C$3.00+2.39%C$3.19C$2.9855,522 shsC$67.16 million06/13/2025C$2.93C$2.93C$2.96C$2.8915,993 shsC$65.60 million06/12/2025C$2.95C$2.93-0.68%C$2.97C$2.9024,563 shsC$65.60 million06/11/2025C$2.86C$2.95+3.15%C$2.99C$2.876,408 shsC$66.05 million06/10/2025C$2.84C$2.86+0.70%C$2.91C$2.7936,633 shsC$64.03 million06/09/2025C$2.84C$2.84C$2.96C$2.8416,250 shsC$63.58 million06/06/2025C$2.90C$2.84-2.07%C$2.93C$2.8423,511 shsC$63.58 million06/05/2025C$2.90C$2.90C$2.92C$2.8322,145 shsC$64.93 million06/04/2025C$2.96C$2.90-2.03%C$3.06C$2.9014,639 shsC$64.93 million06/03/2025C$2.93C$2.96+1.02%C$3.02C$2.9033,290 shsC$66.27 million06/02/2025C$2.89C$2.93+1.38%C$2.99C$2.9138,437 shsC$65.60 million Related Companies Canopy Growth Stock Chart Cipher Pharmaceuticals Stock Chart Organigram Stock Chart Cardiol Therapeutics Stock Chart BioSyent Stock Chart HLS Therapeutics Stock Chart SugarBud Craft Growers Stock Chart Voyageur Pharmaceuticals Stock Chart MediPharm Labs Stock Chart Willow Biosciences Stock Chart Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:MDP) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredMake 22x more from this summer’s Bitcoin boomBitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
